Metronidazole vs Pembrolizumab
Metronidazole vs Pembrolizumab: Overview
This comparison examines the pharmacological differences between Metronidazole and Pembrolizumab.
Mechanism of Action
Metronidazole: Forms cytotoxic free radicals that damage bacterial DNA.
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Pharmacokinetics
Half-life: Metronidazole — 8 hours; Pembrolizumab — 26 days.
Chemical Properties
Molecular Formula: Metronidazole — C6H9N3O3.
Molecular Weight: Metronidazole — 171.1540 g/mol.
Type: Metronidazole — Small molecule; Pembrolizumab — Antibody.